NAFL disease

San Diego-based Viscient Biosciences has announced collaboration with Organovo to help establish a disease model for Non-Alcoholic Fatty Liver (NAFL) disease in bio-printed 3D liver samples. The CEO Taylor Crouch stated that their 3D disease models have the unique capability to demonstrate drug mechanisms of action and efficacy in a setting that closely mimics human livers.

Source: https://www.xconomy.com/san-diego/2017/11/06/new-biotech-viscient-partners-with-organovo-on-fatty-liver-disease/?single_page=true